Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. Co. offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Co. operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes.
When researching a stock like Bio-Rad Laboratories, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BIO Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BIO stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the BIO 200 day moving average ("BIO 200 DMA"), while one of the most popular "shorter look-backs" is the BIO 50 day moving average ("BIO 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Bio-Rad Laboratories. |
Free BIO Email Alerts:
Video: Technical Analysis